DMC Global adopts poison pill with 10% trigger; continues strategic review of two units

DMC Global Inc.

Rights plan effective June 5, 2024, expires June 4, 2025; one right per share as of June 17, 2024.
Trigger at 10% (20% for passive investors); upon trigger, rights allow purchase of shares at $75 with 2x market value.
Board may exchange one common share per right (excluding triggering person) after trigger event.
Board continuing strategic review of DynaEnergetics and NobelClad, considering sale, merger, or investment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.